Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

BETH M LEVENTHAL

Allopathic & Osteopathic Physicians Internal Medicine Nephrology

NPI
1265468797
CMS profile
1225415
Location
PEMBROKE PINES, FL

General Payments · PY2018–2024

$3,924.84

  • Reported across 88 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$2,370.94

16 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $2,000.00 1
Food and Beverage $370.94 15

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $201.35 10
PY2019 $371.19 17
PY2020 $75.58 5
PY2021 $342.24 15
PY2022 $209.45 9
PY2023 $354.09 16
PY2024 $2,370.94 16

Payment records · PY2024 (16)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Ardelyx, Inc. $24.00 12/12/2024 Food and Beverage Undisputed 01/23/2026 1146681005 CMS
AstraZeneca Pharmaceuticals LP $29.56 01/12/2024 Food and Beverage Undisputed 01/23/2026 1105548731 CMS
Aurinia Pharma U.S., Inc. $15.49 01/24/2024 Food and Beverage Undisputed 01/23/2026 1150680361 CMS
Aurinia Pharma U.S., Inc. $27.40 02/20/2024 Food and Beverage Undisputed 01/23/2026 1150680363 CMS
Bayer Healthcare Pharmaceuticals Inc. $13.71 01/17/2024 Food and Beverage Undisputed 01/23/2026 1086115084 CMS
Bayer Healthcare Pharmaceuticals Inc. $20.33 11/21/2024 Food and Beverage Undisputed 01/23/2026 1086165762 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $20.64 02/05/2024 Food and Beverage Undisputed 01/23/2026 1117939348 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $13.60 12/19/2024 Food and Beverage Undisputed 01/23/2026 1117939346 CMS
CALLIDITAS THERAPEUTICS US INC. $22.50 03/13/2024 Food and Beverage Undisputed 01/23/2026 1141511245 CMS
CALLIDITAS THERAPEUTICS US INC. $87.93 03/26/2024 Food and Beverage Undisputed 01/23/2026 1141512297 CMS
CALLIDITAS THERAPEUTICS US INC. $2,000.00 12/01/2024 Consulting Fee Undisputed 01/23/2026 1141528257 CMS
GlaxoSmithKline, LLC. $24.78 02/12/2024 Food and Beverage Undisputed 01/23/2026 1116578796 CMS
Otsuka America Pharmaceutical, Inc. $17.12 10/03/2024 Food and Beverage Undisputed 01/23/2026 1118894554 CMS
Travere Therapeutics, Inc. $12.98 02/29/2024 Food and Beverage Undisputed 01/23/2026 1149939702 CMS
Travere Therapeutics, Inc. $33.89 04/09/2024 Food and Beverage Undisputed 01/23/2026 1149939694 CMS
Travere Therapeutics, Inc. $7.01 09/17/2024 Food and Beverage Undisputed 01/23/2026 1149939698 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.